Evidence map›Paper›PMID 36571386›Full record

ArticleAnnals of neurology2023

Health Conditions Associated with Alzheimer's Disease and Vascular Dementia.

Lori L Beason-Held, Cailey I Kerley, Shikha Chaganti, Abhay Moghekar, Madhav Thambisetty, Luigi Ferrucci, Susan M Resnick, Bennett A Landman

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The enigma of vascular dementia: current state and emerging perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lori L Beason-HeldNational Institute on Aging Intramural Research Program, Baltimore, Maryland, USA.ORCID 0000-0001-9057-6270
Cailey I KerleyDepartment of Electrical and Computer Engineering, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0002-0866-8617
Shikha ChagantiDepartment of Electrical and Computer Engineering, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0002-7029-2665
Abhay MoghekarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-9464-1551
Madhav ThambisettyNational Institute on Aging Intramural Research Program, Baltimore, Maryland, USA.ORCID 0000-0002-2200-2299
Luigi FerrucciNational Institute on Aging Intramural Research Program, Baltimore, Maryland, USA.ORCID 0000-0002-6273-1613
Susan M ResnickNational Institute on Aging Intramural Research Program, Baltimore, Maryland, USA.ORCID 0000-0003-1115-7145
Bennett A LandmanDepartment of Electrical and Computer Engineering, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0001-5733-2127
Institute on Aging · USVanderbilt University · USJohns Hopkins University · US

Funding

The Baltimore Longitudinal Study Of AgingZIAAG000015 · NIA · NATIONAL INSTITUTE ON AGING · PI SIMONSICK, ELEANOR MARIE · 2009 to 2025
$116.9M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
Early Markers of Alzheimer DiseaseZIAAG000185 · NIA · NATIONAL INSTITUTE ON AGING · PI WALKER, KEENAN · 2009 to 2025
$20.4M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
New Cures from Old Medicines - Targeting abnormal metabolism in Alzheimer's DiseaseZIAAG000436 · NIA · NATIONAL INSTITUTE ON AGING · PI RESNICK, SUSAN · 2019 to 2024
$950k
Intramural NIH HHS Z99 AG999999
6 · The paper itself

Abstract

objectiveWe examined medical records to determine health conditions associated with dementia at varied intervals prior to dementia diagnosis in participants from the Baltimore Longitudinal Study of Aging (BLSA).

methodsData were available for 347 Alzheimer's disease (AD), 76 vascular dementia (VaD), and 811 control participants without dementia. Logistic regressions were performed associating International Classification of Diseases, 9th Revision (ICD-9) health codes with dementia status across all time points, at 5 and 1 year(s) prior to dementia diagnosis, and at the year of diagnosis, controlling for age, sex, and follow-up length of the medical record.

resultsIn AD, the earliest and most consistent associations across all time points included depression, erectile dysfunction, gait abnormalities, hearing loss, and nervous and musculoskeletal symptoms. Cardiomegaly, urinary incontinence, non-epithelial skin cancer, and pneumonia were not significant until 1 year before dementia diagnosis. In VaD, the earliest and most consistent associations across all time points included abnormal electrocardiogram (EKG), cardiac dysrhythmias, cerebrovascular disease, non-epithelial skin cancer, depression, and hearing loss. Atrial fibrillation, occlusion of cerebral arteries, essential tremor, and abnormal reflexes were not significant until 1 year before dementia diagnosis.

interpretationThese findings suggest that some health conditions are associated with future dementia beginning at least 5 years before dementia diagnosis and are consistently seen over time, while others only reach significance closer to the date of diagnosis. These results also show that there are both shared and distinctive health conditions associated with AD and VaD. These results reinforce the need for medical intervention and treatment to lessen the impact of health comorbidities in the aging population. ANN NEUROL 2023;93:805-818.

Indexed as

Alzheimer DiseaseCerebrovascular DisordersDementia, VascularAgedComorbidityHumansLongitudinal StudiesMale

Identifiers

PMID36571386
PMCPMC11973975
OpenAlexW4312154093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.